Khalid Tinasti, Ann Fordham et David Bewley-Taylor demandent quels seront les effets d’un changement de leadership à l’OMS et au PNUD sur les positions de ces organisations en ce qui concerne les politiques des drogues et la réduction des risques. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues. 


The UN General Assembly Special Session on drugs held in April 2016 has been organized by the international drug control entities, but has confirmed the inclusion of other UN agencies in the global debates on drugs. Out of these, WHO and UNDP have played a major role in linking drug policy with the priorities of protecting human rights and promoting sustainable development. In May 2017, the leadership of both agencies will change. This letter reviews the aspiring leaders of these agencies’ positions on drug policies through existing literature, providing more clarity on their past or current commitment to the issue of drug policy and harm reduction stakeholders.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.